![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer
Prarthna V Bhardwaj, Yara Abdou
The Oncologist (2023) Vol. 28, Iss. 10, pp. 832-844
Open Access | Times Cited: 8
Prarthna V Bhardwaj, Yara Abdou
The Oncologist (2023) Vol. 28, Iss. 10, pp. 832-844
Open Access | Times Cited: 8
Showing 8 citing articles:
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
The prognostic utility of the ratio of lymphocyte to monocyte in patients with metastatic colorectal cancer: a systematic review and meta-analysis
Pingping Mei, Lixin Huang, Lin Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Pingping Mei, Lixin Huang, Lin Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Pralay Mukhopadhyay, Hesham Abdullah, Joanna Opalinska, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Pralay Mukhopadhyay, Hesham Abdullah, Joanna Opalinska, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer
Masayuki Nagahashi, Yasuo Miyoshi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3354-3354
Open Access | Times Cited: 4
Masayuki Nagahashi, Yasuo Miyoshi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3354-3354
Open Access | Times Cited: 4
Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy
Xiangyun You, Chunming Zhu, Puguang Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116152-116152
Open Access | Times Cited: 3
Xiangyun You, Chunming Zhu, Puguang Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116152-116152
Open Access | Times Cited: 3
Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis
Ping Yang, Guoshuang Shen, Hengheng Zhang, et al.
International Immunopharmacology (2024) Vol. 133, pp. 111961-111961
Closed Access | Times Cited: 2
Ping Yang, Guoshuang Shen, Hengheng Zhang, et al.
International Immunopharmacology (2024) Vol. 133, pp. 111961-111961
Closed Access | Times Cited: 2
Updates in Treatment of HER2-positive Metastatic Breast Cancer
A. Avelino, Soumya Pulipati, Kevin Tony Jamouss, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 2
A. Avelino, Soumya Pulipati, Kevin Tony Jamouss, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 2
Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Pingping Mei, Wenzhe Feng, Yanrong Zhan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Pingping Mei, Wenzhe Feng, Yanrong Zhan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Expert consensus on the clinical application of immunotherapy in breast cancer: 2024
Kun Wang, Jin Yang, Biyun Wang, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 9-9
Open Access
Kun Wang, Jin Yang, Biyun Wang, et al.
Translational Breast Cancer Research (2024) Vol. 5, pp. 9-9
Open Access
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access